Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273867 · ClinicalTrials.gov registry record
Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 60
- Enrollment target
NCT04273867: Completed study, sponsored by Weill Medical College of Cornell University.
NCT04273867 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04273867 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The objective of this study is to administer and validate a disease specific health related quality of life (HRQOL) survey for patients with Chronic Hypersensitivity Pneumonitis (CHP).
Primary Outcome
The newly developed survey that is being validated consists of 42 items that assess the impact that Hypersensitivity Pneumonitis has on daily life for those who have the disease.
Interventions
- OTHER Chronic Hypersensitivity Pneumonitis Health Related Quality of Life Survey Instrument
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-07-10 |
| Est. Completion | 2023-02-22 |
What the finished NCT04273867 record still lists
NCT04273867 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Chronic Hypersensitivity Pneumonitis Health Related Quality of Life Survey Instrument is the first listed.
NCT04273867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04273867 about?
NCT04273867 is a clinical study titled "Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis". The objective of this study is to administer and validate a disease specific health related quality of life (HRQOL) survey for patients with Chronic Hypersensitivity Pneumonitis (CHP).
What is the current status of trial NCT04273867?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-07-10. Estimated completion is 2023-02-22.
What interventions are being tested in trial NCT04273867?
The interventions under investigation include: Chronic Hypersensitivity Pneumonitis Health Related Quality of Life Survey Instrument (OTHER).
Who is sponsoring clinical trial NCT04273867?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI